LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 ...
The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...
Medical Device Network on MSN
Stereotaxis secures FDA approval for ablation catheter
The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...
Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...
For high-risk patients, the method could offer a safer alternative to open-heart surgery.
CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Dr. Peter Weiss, one of the biggest boosters of robotic magnetic navigation, offers his perspective on the needs of EPs and ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback